Through Calls for Proposals, we find smart new ideas to help to alleviate the burden of diseases such as HIV/AIDS, tuberculosis and malaria, which often affect the poorest people in society.
Unitaid is pleased to announce a new Call for Proposals on the area for intervention: Accelerating tools to drive tuberculosis (TB) detection.
Unitaid is pleased to announce a new Call for Proposals in the Area for Intervention: New tools for reducing maternal mortality.
Under this Call, Unitaid is soliciting proposals aimed at accelerating the adoption and scale-up of IPTi in moderate-to-high transmission settings.
In the context of maternal and child health, Unitaid has identified the opportunity to support the elimination target of congenital transmission of Chagas disease in endemic countries.
For the purpose of this call, Unitaid defines ‘long-acting products’ to mean sustained/extended release products that allow slow absorption of administered drugs maintaining their effects over long periods of time (i.e., over a week for oral products, over a month for injectables and other devices such as implants, patches or rings). The expected change in public health impact for the new products, compared to current daily oral formulations, would need to be explained in each case as it differs depending on disease and indication.
More than one-third of the world’s population – over 2.5 billion people – is at risk of Plasmodium vivax (P. vivax) malaria – the second most common species of malaria. P. vivax occurs in high burden countries but also accounts for over 70% of malaria cases in countries approaching elimination. It can cause severe disease and death, and represents a major financial burden to patients and their caregivers. High-risk groups include migrant populations, the rural poor, and other marginalized groups, as well as children under 5 who have the greatest chance of suffering negative health consequences as a result of their infection.
Under this Call, Unitaid is soliciting proposals for the following interventions aimed at accelerating the availability, adoption and scale-up of improved tools to identify severe disease.
Unitaid seeks to widen access to the best tools for cervical cancer prevention in low- and middle-income countries.